Clinical Trial Update: Glycine to Treat Psychotic Disorders in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glycine for treating psychotic disorders in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Glycine (glycine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Psychotic Disorder, Schizoaffecitve Disorder | Phase 2 | Status: COMPLETED